# 2025 ESC/EACTS Valvular Heart Disease Guidelines Summary
> Explore the 2025 ESC/EACTS updates on Valvular Heart Disease, featuring new TAVI age thresholds, TEER recommendations, and multimodality imaging protocols.

Tags: cardiology, heart-disease, medical-guidelines, tavi, cardiac-surgery, echocardiography, healthcare, esc-guidelines
## ESC/EACTS 2025 Valvular Heart Disease Guidelines
* Updated recommendations from the European Society of Cardiology & European Association for Cardio-Thoracic Surgery.
* Focus on a multi-disciplinary Heart Team approach and lifetime patient management.

## Heart Team & Heart Valve Centres
* Class I Recommendation for heart valve centres to perform ≥100 procedures/year (≥50 TAVI, ≥25 SAVR).
* Core team includes imaging cardiologists, interventional cardiologists, and cardiac surgeons.

## Diagnostic & Imaging Advances
* CCTA is now a Class I recommendation before valve interventions for patients with moderate or low CAD risk.
* Emphasis on 3D Echo, CMR for myocardial fibrosis, and NT-proBNP for risk stratification.

## Aortic Stenosis (AS) Updates
* TAVI preference age cutoff lowered from 75 to ≥70 years.
* Early intervention (Class IIa) recommended for asymptomatic severe high-gradient AS in low-risk patients with LVEF >50%.

## Mitral & Tricuspid Regurgitation
* TEER upgraded to Class I for ventricular secondary MR meeting COAPT criteria.
* Tricuspid concomitant repair is Class I; isolated TR surgery or transcatheter TEER is Class IIa.

## Prosthetic Valves & Antithrombotics
* Mechanical valves require VKA (target INR 2.5-4.0 depending on position).
* Bioprosthetic valves: DOACs may be considered in select patients after the first 3 months post-implant.
---
This presentation was created with [Bobr AI](https://bobr.ai) — an AI presentation generator.